Scpharmaceuticals Inc (SCPH) Financials

$5.67

$0.00 (0.00%)

As on 08-Oct-2025 09:30EDT

Market cap

$304 Mln

Revenue (TTM)

$50 Mln

P/E Ratio

--

P/B Ratio

28.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	49.97	36.33	13.59	2.06	--	--
Cost of Revenue	15.76	11.36	3.81	0.47	0.44	0.40
Gross Profit	34.21	24.97	9.78	-0.47	-0.44	-0.40
Operating Expenses	100.75	89.75	65.18	36.16	25.82	29.93
Operating Profit (EBIT)	-66.54	-64.78	-55.40	-36.16	-25.82	-29.93
Other Income	--	--	--	2.62	0.36	0.31
Profit before Tax	-91.72	-85.15	-54.81	-36.84	-28.03	-32.21
Provision for Tax	-0.01	--	0.46	0.68	2.45	2.18
Profit after Tax (Net Income)	-91.72	-85.15	-54.81	-36.84	-28.03	-32.21
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-36.84	-28.03	-32.21

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-21.32	13.32	37.22	72.43	56.47	82.17
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	81.14	79.32	44.13	44.35	7.72	17.56
Current Liabilities	20.43	14.88	13.13	7.42	14.85	9.32
Total Liabilities	100.69	107.52	94.48	124.20	79.04	109.05

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	1.53	1.67	1.54	0.89	0.76	1.22
Current Assets	78.73	105.85	92.94	123.31	78.28	107.83
Total Assets	100.69	107.52	94.48	124.20	79.04	109.05
Total Debt*	52.45	52.69	40.27	37.37	17.64	20.21
Net Current Assets	58.30	90.97	79.80	115.89	63.43	98.51

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-70.54	-59.24	-34.58	-27.15	-27.69
Cash Flow from Investing Activities	--	29.30	19.97	-45.86	32.13	-33.46
Cash from Financing Activities	--	70.08	14.85	77.23	-2.53	60.35
Net Cash Inflow / Outflow	--	--	--	-3.21	2.45	-0.81

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-1.88	-1.91	-1.41	-1.18	-1.02	-1.18
Cash EPS ($)	--	-1.91	-1.40	-1.16	-1.01	-1.16
Adjusted Book Value ($)	--	0.30	0.96	2.32	2.06	3.01
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.58	-1.53	-1.11	-0.99	-1.01
Free Cash Flow per Share ($)	--	-1.58	-1.53	-1.11	-0.99	-1.01

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-118.67	-58.53	-40.06	-31.77	-37.02
ROE (%)	--	-336.97	-99.97	-57.16	-40.44	-48.24
ROA (%)	-102.43	-84.31	-50.13	-36.25	-29.81	-34.57
EBIT Margin (%)	-165.35	-213.53	-343.46	-1,625.59	--	--
Net Margin (%)	-183.55	-234.36	-403.22	-786.46	-7,701.65	-10,356.59
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	107.79	1.67	5.59	--	--	--
EBIT Growth (%)	-58.11	-66.17	-39.21	-31.73	14.05	5.15
Net Profit Growth (%)	-51.24	-55.35	-48.79	-31.40	12.96	6.41
EPS Growth (%)	-20.55	-0.35	-0.20	-0.15	0.13	0.36
Book Value Growth (%)	-267.23	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-1.85	-4.44	-6.08	-4.90	-4.49
Price / Book Value	28.45	11.83	6.53	3.09	2.43	1.76
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-6.69	-1.73	-4.50	-4.33	-3.19	-2.04
Close Price ($)	3.81	3.54	6.27	7.17	5.02	5.29
High Price ($)	5.65	6.60	12.75	7.96	8.20	11.99
Low Price ($)	1.94	3.08	4.63	3.68	3.48	5.00
Market Cap ($ Cr)	304.36	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	-2.40	3.96	1.08	0.52	0.31	0.25
Short term debt to equity ratio	-0.01	0.04	0.01	0.02	0.18	0.03
Current Ratio	3.85	7.12	7.08	16.63	5.27	11.57
Quick Ratio	3.14	6.18	6.40	16.46	5.27	--
Interest Coverage	-13.98	-10.25	-5.75	-10.16	-9.89	-11.45

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	38.84	32.26	33.02	110.62	--	--
Asset Turnover	0.56	0.36	0.12	0.02	--	--
Receivable days	--	81.48	90.97	404.02	--	--
Inventory Days	--	365.59	482.56	479.98	--	2,230.86
Payable days	--	126.73	264.47	804.64	921.46	1,285.24
Cash Conversion Cycle	--	320.33	309.06	79.36	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.